Eric D Weinhandl1,2, James B Wetmore3,4, Yi Peng3, Jiannong Liu3, David T Gilbertson3, Kirsten L Johansen3,4. 1. Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota eric.weinhandl@cdrg.org. 2. Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, Minnesota. 3. Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota. 4. Division of Nephrology, Hennepin Healthcare, Minneapolis, Minnesota.
Abstract
BACKGROUND: Reports from around the world have indicated a fatality rate of patients with coronavirus disease 2019 (COVID-19) in the range of 20%-30% among patients with ESKD. Population-level effects of COVID-19 on patients with ESKD in the United States are uncertain. METHODS: We identified patients with ESKD from Centers for Medicare and Medicaid Services data during epidemiologic weeks 3-27 of 2017-2020 and corresponding weeks of 2017-2019, stratifying them by kidney replacement therapy. Outcomes comprised hospitalization for COVID-19, all-cause death, and hospitalization for reasons other than COVID-19. We estimated adjusted relative rates (ARRs) of death and non-COVID-19 hospitalization during epidemiologic weeks 13-27 of 2020 (March 22 to July 4) versus corresponding weeks in 2017-2019. RESULTS: Among patients on dialysis, the rate of COVID-19 hospitalization peaked between March 22 and April 25 2020. Non-Hispanic Black race and Hispanic ethnicity associated with higher rates of COVID-19 hospitalization, whereas peritoneal dialysis was associated with lower rates. During weeks 13-27, ARRs of death in 2020 versus 2017-2019 were 1.17 (95% confidence interval [95% CI], 1.16 to 1.19) and 1.30 (95% CI, 1.24 to 1.36) among patients undergoing dialysis or with a functioning transplant, respectively. Excess mortality was higher among non-Hispanic Black, Hispanic, and Asian patients. Among patients on dialysis, the rate of non-COVID-19 hospitalization during weeks 13-27 in 2020 was 17% lower versus hospitalization rates for corresponding weeks in 2017-2019. CONCLUSIONS: During the first half of 2020, the clinical outcomes of patients with ESKD were greatly affected by COVID-19, and racial and ethnic disparities were apparent. These findings should be considered in prioritizing administration of COVID-19 vaccination.
BACKGROUND: Reports from around the world have indicated a fatality rate of patients with coronavirus disease 2019 (COVID-19) in the range of 20%-30% among patients with ESKD. Population-level effects of COVID-19 on patients with ESKD in the United States are uncertain. METHODS: We identified patients with ESKD from Centers for Medicare and Medicaid Services data during epidemiologic weeks 3-27 of 2017-2020 and corresponding weeks of 2017-2019, stratifying them by kidney replacement therapy. Outcomes comprised hospitalization for COVID-19, all-cause death, and hospitalization for reasons other than COVID-19. We estimated adjusted relative rates (ARRs) of death and non-COVID-19 hospitalization during epidemiologic weeks 13-27 of 2020 (March 22 to July 4) versus corresponding weeks in 2017-2019. RESULTS: Among patients on dialysis, the rate of COVID-19 hospitalization peaked between March 22 and April 25 2020. Non-Hispanic Black race and Hispanic ethnicity associated with higher rates of COVID-19 hospitalization, whereas peritoneal dialysis was associated with lower rates. During weeks 13-27, ARRs of death in 2020 versus 2017-2019 were 1.17 (95% confidence interval [95% CI], 1.16 to 1.19) and 1.30 (95% CI, 1.24 to 1.36) among patients undergoing dialysis or with a functioning transplant, respectively. Excess mortality was higher among non-Hispanic Black, Hispanic, and Asian patients. Among patients on dialysis, the rate of non-COVID-19 hospitalization during weeks 13-27 in 2020 was 17% lower versus hospitalization rates for corresponding weeks in 2017-2019. CONCLUSIONS: During the first half of 2020, the clinical outcomes of patients with ESKD were greatly affected by COVID-19, and racial and ethnic disparities were apparent. These findings should be considered in prioritizing administration of COVID-19 vaccination.
Authors: Sameer S Kadri; Jake Gundrum; Sarah Warner; Zhun Cao; Ahmed Babiker; Michael Klompas; Ning Rosenthal Journal: JAMA Date: 2020-12-22 Impact factor: 56.272
Authors: Bridget H Garrity; Holly Kramer; Kavitha Vellanki; David Leehey; Julia Brown; David A Shoham Journal: Hemodial Int Date: 2015-06-10 Impact factor: 1.812
Authors: Kathleen Dooling; Mona Marin; Megan Wallace; Nancy McClung; Mary Chamberland; Grace M Lee; H Keipp Talbot; José R Romero; Beth P Bell; Sara E Oliver Journal: MMWR Morb Mortal Wkly Rep Date: 2021-01-01 Impact factor: 35.301
Authors: Matthew T Oetjens; Jonathan Z Luo; Alexander Chang; Joseph B Leader; Dustin N Hartzel; Bryn S Moore; Natasha T Strande; H Lester Kirchner; David H Ledbetter; Anne E Justice; David J Carey; Tooraj Mirshahi Journal: PLoS One Date: 2020-11-12 Impact factor: 3.240
Authors: Katherine Mackey; Chelsea K Ayers; Karli K Kondo; Somnath Saha; Shailesh M Advani; Sarah Young; Hunter Spencer; Max Rusek; Johanna Anderson; Stephanie Veazie; Mia Smith; Devan Kansagara Journal: Ann Intern Med Date: 2020-12-01 Impact factor: 25.391
Authors: Kitty J Jager; Anneke Kramer; Nicholas C Chesnaye; Cécile Couchoud; J Emilio Sánchez-Álvarez; Liliana Garneata; Fréderic Collart; Marc H Hemmelder; Patrice Ambühl; Julia Kerschbaum; Camille Legeai; María Dolores Del Pino Y Pino; Gabriel Mircescu; Lionel Mazzoleni; Tiny Hoekstra; Rebecca Winzeler; Gert Mayer; Vianda S Stel; Christoph Wanner; Carmine Zoccali; Ziad A Massy Journal: Kidney Int Date: 2020-10-15 Impact factor: 10.612
Authors: Jennifer E Flythe; Magdalene M Assimon; Matthew J Tugman; Emily H Chang; Shruti Gupta; Jatan Shah; Marie Anne Sosa; Amanda DeMauro Renaghan; Michal L Melamed; F Perry Wilson; Javier A Neyra; Arash Rashidi; Suzanne M Boyle; Shuchi Anand; Marta Christov; Leslie F Thomas; Daniel Edmonston; David E Leaf Journal: Am J Kidney Dis Date: 2020-09-19 Impact factor: 11.072
Authors: Wenbo Wu; Garrett W Gremel; Kevin He; Joseph M Messana; Ananda Sen; Jonathan H Segal; Claudia Dahlerus; Richard A Hirth; Jian Kang; Karen Wisniewski; Tammie Nahra; Robin Padilla; Lan Tong; Haoyu Gu; Xi Wang; Megan Slowey; Ashley Eckard; Xuemei Ding; Lisa Borowicz; Juan Du; Brandon Frye; John D Kalbfleisch Journal: Kidney360 Date: 2022-04-15
Authors: James B Wetmore; Kirsten L Johansen; Jiannong Liu; Yi Peng; David T Gilbertson; Eric D Weinhandl Journal: J Am Soc Nephrol Date: 2021-09-17 Impact factor: 14.978
Authors: Jeffrey Silberzweig; J Ganesh Bhat; Mary O Dittrich; Raghu Durvasula; Jeff Giullian; Jeffrey L Hymes; Doug Johnson; Brigitte Schiller; Richard Spech; Leslie Spry; Geoffrey Scott Walker; Suzanne Watnick; Jerry Yee; Barry I Freedman Journal: J Am Soc Nephrol Date: 2022-06-02 Impact factor: 14.978
Authors: Stephen Salerno; Joseph M Messana; Garrett W Gremel; Claudia Dahlerus; Richard A Hirth; Peisong Han; Jonathan H Segal; Tao Xu; Dan Shaffer; Amy Jiao; Jeremiah Simon; Lan Tong; Karen Wisniewski; Tammie Nahra; Robin Padilla; Kathryn Sleeman; Tempie Shearon; Sandra Callard; Alexander Yaldo; Lisa Borowicz; Wilfred Agbenyikey; Golden M Horton; Jesse Roach; Yi Li Journal: JAMA Netw Open Date: 2021-11-01